These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8079062)

  • 1. Low serum albumin and the increased risk of amikacin nephrotoxicity.
    Contreras AM; Ramírez M; Cueva L; Alvarez S; de Loza R; Gamba G
    Rev Invest Clin; 1994; 46(1):37-43. PubMed ID: 8079062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoalbuminemia as a risk factor for amikacin nephrotoxicity.
    Gamba G; Contreras AM; Cortés J; Nares F; Santiago Y; Espinosa A; Bobadilla J; Jiménez Sánchez G; López G; Valadez A
    Rev Invest Clin; 1990; 42(3):204-9. PubMed ID: 2270367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amikacin nephrotoxicity in patients with chronic liver disease.
    Cortés J; Gamba G; Contreras A; Peña JC
    Rev Invest Clin; 1990; 42(2):93-8. PubMed ID: 2267454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
    Sweileh WM
    Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of amikacin nephrotoxicity in the hematology/oncology population.
    Kiel PJ; Lo M; Stockwell D; Patel GP
    Am J Ther; 2008; 15(2):131-6. PubMed ID: 18356633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
    Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
    Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity induced by gentamicin and amikacin.
    Smith CR; Maxwell RR; Edwards CQ; Rogers JF; Lietman PS
    Johns Hopkins Med J; 1978 Mar; 142(3):85-90. PubMed ID: 342789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amikacin nephrotoxicity. Incidence, clinical course and risk factors. A prospective study in a teaching hospital.
    Gamba G; Arizpe D; Ferral H; Contreras AM; Cortés J; Mendoza A; Malé R; Viniegra L; Peña JC
    Rev Invest Clin; 1988; 40(2):135-40. PubMed ID: 3175367
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gentamicin and amikacin nephrotoxicity: comparative study in patients with initially normal renal function].
    Ballesteros J; Northland R; Wolff M
    Rev Med Chil; 1989 Jan; 117(1):10-7. PubMed ID: 2641618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and technique survival in continuous ambulatory peritoneal dialysis in a single center of the west of Mexico.
    Rojas-Campos E; Alcántar-Medina M; Cortés-Sanabria L; Martínez-Ramírez HR; Camarena JL; Chávez S; Flores A; Nieves JJ; Monteón F; Gómez-Navarro B; Cueto-Manzano AM
    Rev Invest Clin; 2007; 59(3):184-91. PubMed ID: 17910410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ototoxicity and pharmacokinetically determined dosages of amikacin in granulocytopenic cancer patients.
    Danhauer FJ; Fortner CL; Schimpff SC; deJongh CA; Wesley MN; Wiernik PH
    Clin Pharm; 1982; 1(6):539-43. PubMed ID: 7185540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
    Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
    J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral.
    Sijpkens YW; Mallat MJ; Siegert CE; Zwinderman AH; Westendorp RG; de Fijter JW; van Es LA; Paul LC
    Clin Nephrol; 2001 Feb; 55(2):149-55. PubMed ID: 11269679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
    Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME
    Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors profile for acute kidney injury after cardiac surgery is different according to the level of baseline renal function.
    Lombardi R; Ferreiro A
    Ren Fail; 2008; 30(2):155-60. PubMed ID: 18300114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.